ChartRow logo
$84.37-2.77%
as of market close, Sep 11, 2026
☾ AH
PeersMRNALLYUNHJNJMRKABBV

EW financial statements

The full income statement, balance sheet, and cash-flow statement for Edwards Lifesciences Corporation (EW), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 602.4M2024-09 589.8M2024-12 587.9M2025-03 586.6M2025-06 587.1M2025-09 580.3M2025-12 580.8M2026-03 575.8M2026-06 576.4M-4.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue6.07B+11.5%5.44B+8.6%5.01B+12.2%4.46B-14.7%5.23B+19.3%
4.73B+9.5%4.32B+7.2%4.03B+7.8%3.74B-6.1%3.98B+20.5%
Cost of revenue1.33B+19.4%1.12B+14.2%978M+35.2%724M-42.1%1.25B+15.6%
Research & development1.08B+2.5%1.05B+9.4%963M+14.1%844M-6.6%903M+18.7%
Selling, general & administrative2.09B+16.5%1.79B+13.1%1.58B+16.6%1.36B-9.1%1.49B+21.6%
Restructuring13.1M-60.2%32.9M
Amortization of intangibles8.40M+50.0%5.60M+154.5%2.20M-4.3%2.30M-70.1%7.70M+42.6%
Operating income1.26B-8.3%1.38B+5.3%1.31B-12.6%1.50B-11.4%1.69B+88.3%
Interest expense20.4M+3.0%19.8M+12.5%17.6M-8.3%19.2M+4.3%18.4M+16.5%
Interest & investment income169M+40.3%120M+79.0%67.2M+89.3%35.5M+104.0%17.4M-25.6%
Net interest income-20.4M-3.0%-19.8M-12.5%-17.6M
Other non-operating income7.20M-89.6%68.9M+395.7%13.9M+189.6%4.80M-62.2%12.7M+10.4%
Pre-tax income1.27B-17.8%1.55B+12.8%1.37B-9.7%1.52B-10.7%1.70B+85.7%
Income tax217M+42.6%152M-0.2%152M-22.0%196M-1.7%199M+113.2%
1.07B-74.3%4.17B+197.7%1.40B-7.9%1.52B+1.3%1.50B+82.5%
Income from continuing operations1.06B-24.3%1.40B+14.5%1.22B-7.6%1.32B
Discontinued operations13.4M-99.5%2.77B+1446.1%179M-9.3%198M
Net income to non-controlling interest-4.10M+16.3%-4.90M-63.3%-3.00M0.000.00
Net income to common1.40B-7.9%1.52B+1.3%1.50B+82.5%
$1.83-73.7%$6.97+203.0%$2.30-5.7%$2.44+2.5%$2.38+83.1%
EPS (basic)$1.84-73.6%$6.98+202.2%$2.31-6.1%$2.46+2.1%$2.41+82.6%
Weighted-avg shares (basic)585M-2.2%598M-1.5%607M-2.0%619M-0.7%623M+0.1%
Weighted-avg shares (diluted)586M-2.3%599M-1.7%609M-2.4%624M-1.1%631M-0.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
6.74B+7.2%6.29B+55.7%4.04B+30.4%3.10B-2.7%3.18B+2.9%
Cash & equivalents2.94B-3.5%3.05B+168.9%1.13B+47.2%769M-10.9%863M-27.1%
Short-term investments1.29B+38.4%931M+86.0%501M+12.1%446M-26.1%604M+175.3%
Accounts receivable660M+8.3%609M-21.0%772M+20.0%643M+10.4%582M+13.1%
Inventory1.13B+3.6%1.09B+20.3%904M+3.2%876M+20.5%727M-9.4%
Prepaid expenses135M+11.6%121M-6.1%129M+17.1%110M+29.1%85.2M+13.4%
Other current assets339M-2.4%348M+54.6%225M+14.8%196M-17.4%237M+13.9%
13.7B+4.9%13.1B+39.4%9.36B+12.9%8.29B-2.5%8.50B+17.5%
Property, plant & equipment1.81B+7.5%1.69B+6.0%1.59B-2.6%1.63B+5.6%1.55B+10.9%
Operating lease right-of-use103M+4.6%98.2M+16.4%84.4M-8.6%92.3M+0.2%92.1M-2.2%
Goodwill1.77B-0.5%1.78B+55.2%1.15B+7.5%1.06B-8.8%1.17B-0.5%
Intangible assets1.13B-4.1%1.18B+194.6%399M+40.0%285M-11.9%324M-2.4%
Long-term investments279M-9.5%308M-47.3%584M-52.9%1.24B-32.5%1.83B+128.8%
Deferred tax assets1.14B+14.7%992M+32.4%749M+54.8%484M+96.2%247M+6.8%
Other non-current assets730M+1.2%722M+55.8%463M+54.9%299M+169.9%111M-7.4%
1.81B+20.5%1.51B+25.9%1.20B+16.9%1.02B-1.0%1.03B+15.5%
Accounts payable228M+15.2%197M+5.8%187M-7.6%202M-1.3%205M+4.1%
Current lease liability24.5M+4.7%23.4M+2.2%22.9M-10.2%25.5M+0.0%25.5M-6.3%
3.36B+12.3%2.99B+13.2%2.64B+6.4%2.49B-6.8%2.67B+0.1%
Long-term debt598M+0.1%598M+0.1%597M+0.1%596M+0.1%596M+0.1%
Non-current lease liability82.6M+4.7%78.9M+21.0%65.2M-6.2%69.5M+0.6%69.1M-5.0%
Operating lease liability (total)107M+4.7%102M+16.1%88.1M-7.3%95.0M+0.4%94.6M-5.3%
Other non-current liabilities362M-2.9%373M+48.5%251M+15.5%218M-18.6%267M+5.9%
10.3B+3.4%10.00B+50.4%6.65B+14.5%5.81B-0.5%5.84B+27.6%
Preferred stock0.000.000.000.000.00
Common stock659M+0.6%655M+0.7%651M+0.6%646M+0.7%642M+0.9%
Additional paid-in capital2.77B+5.9%2.61B+14.9%2.27B+15.5%1.97B+15.8%1.70B+18.2%
Retained earnings14.2B+8.2%13.2B+46.4%8.99B+18.5%7.59B+25.1%6.07B+32.9%
Treasury stock7.09B+14.5%6.19B+23.2%5.02B+21.2%4.14B+71.5%2.42B+26.9%
Accumulated other comprehensive income-238M+2.5%-245M-0.7%-243M+4.7%-255M-61.6%-158M+2.1%
Non-controlling interest0.00-100.0%64.5M-7.1%69.4M0.00
Total equity incl. non-controlling10.3B+2.7%10.1B+49.8%6.72B+15.7%5.81B-0.5%5.84B+27.6%
Total liabilities & equity13.7B+4.9%13.1B+39.4%9.36B+12.9%8.29B-2.5%8.50B+17.5%
Common shares issued659M+0.6%655M+0.7%651M+0.6%646M+0.7%642M+0.9%
Common shares outstanding581M-1.3%589M-2.1%601M-1.2%608M-2.5%624M-0.0%
Shares outstanding (cover)581M-1.2%588M-2.2%601M-1.2%608M-2.4%623M-0.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.60B+194.2%542M-39.5%896M-26.5%1.22B-29.7%1.73B+64.3%
Depreciation & amortization157M+0.9%155M+7.1%145M+3.8%140M+3.6%135M+25.7%
Intangible amortization8.40M+50.0%5.60M+154.5%2.20M-4.3%2.30M-70.1%7.70M+42.6%
Share-based compensation158M-2.6%162M+16.4%139M+9.9%127M+16.0%109M+18.0%
Deferred income taxes-65.8M+59.6%-163M+32.8%-242M+7.4%-262M-494.8%-44.0M+15.7%
Change in inventory-50.7M-119.8%256M-11.4%289M+35.4%213M+1223.2%-19.0M-115.8%
-713M-130.8%2.31B+1230.8%174M-31.1%252M+114.6%-1.72B-224.3%
Capital expenditure260M+3.1%252M-0.2%253M+3.4%245M-24.9%326M-20.0%
Free cash flow1.33B+360.5%290M-54.9%643M-34.0%974M-30.8%1.41B+117.3%
Acquisitions0.000.000.000.000.00
Other investing activities7.40M-41.3%12.6M+481.8%-3.30M-111.5%28.8M-35.1%44.4M+266.9%
-957M+2.7%-983M-38.3%-711M+55.1%-1.58B-344.7%-356M+26.8%
Long-term debt issued0.000.000.000.00-100.0%5.20M-67.9%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased893M-22.9%1.16B+31.8%880M-49.1%1.73B+236.8%513M-18.0%
Dividends paid0.000.000.000.000.00
Other financing activities-3.80M-22.6%-3.10M-138.5%-1.30M+65.8%-3.80M-1166.7%-300K+75.0%
FX effect on cash-44.8M-216.1%38.6M+129.8%16.8M-12.5%19.2M+38.1%13.9M+167.8%
Net change in cash-119M-106.2%1.91B+409.0%375M+496.0%-94.8M+71.5%-333M-2206.3%
Interest paid20.2M+3.1%19.6M-1.5%19.9M+3.1%19.3M-4.5%20.2M+1.5%
Income taxes paid490M-59.0%1.20B+154.4%470M-6.7%504M+176.2%183M-7.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap49.5B+13.8%43.5B-5.9%46.2B+0.3%46.1B-42.9%80.7B+41.7%
P/E46.1×+342.4%10.4×-67.7%32.3×+2.2%31.6×-41.1%53.7×-22.4%
P/S8.2×+2.0%8.0×-27.8%11.1×+28.8%8.6×-44.3%15.4×+18.8%
P/B4.8×+10.0%4.4×-37.3%6.9×-6.4%7.4×-46.4%13.8×+11.1%
P/FCF37.1×-75.3%150.1×+162.4%57.2×+29.4%44.2×-23.0%57.4×-34.8%
Earnings yield2.2%-77.4%9.6%+210.0%3.1%-2.2%3.2%+69.9%1.9%+28.8%
FCF yield2.7%+304.8%0.67%-61.9%1.7%-22.7%2.3%+29.9%1.7%+53.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: EW’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all EW filings on SEC EDGAR → Not investment advice.